JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209584200 on March 26, 2003

J. Biol. Chem., Vol. 278, Issue 22, 20162-20170, May 30, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/22/20162    most recent
M209584200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Z.
Right arrow Articles by Uhl, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Z.
Right arrow Articles by Uhl, G. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites*

Zhicheng Lin, Ping-Wu Zhang {ddagger}, Xuguang Zhu {ddagger}, Jean-Marc Melgari {ddagger}, Robin Huff, Rachel L. Spieldoch and George R. Uhl §

From the Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, Baltimore, Maryland 21224

The dopamine transporter (DAT) modulates dopamine neurotransmission and is a primary target for psychostimulant influences on locomotion and reward. Selective DAT expression by dopaminergic neurons has led to use of cocaine analog DAT radioligands to assess rates of progression of dopamine neuronal degeneration in Parkinson's disease. We have documented that DAT is a phosphoprotein that is regulated by phosphorylation through pathways that include protein kinase C cascades. We now extend this work using drugs selective for phosphatidylinositol 3-kinase (PI3K), protein kinase C, MEK1/2, p38 kinase, and Ca2+/calmodulin kinase II. We compare the drug effects on wild type DAT to the effects on 20 DAT mutants and a DAT deletion. PI3K and MEK1/2 modulators exert strong effects on DAT expression patterns and dopamine uptake Vmax. PKC principally modulates Vmax. Neither p38 nor Ca2+/calmodulin kinase II agents exert significant influences on wild type DAT. Several mutants and a DAT with an N-terminal deletion display alterations that interact with the effects of kinase modulators, especially S7A for PKC effects; T62A, S581A, and T612A for PI3K effects; and S12A and T595A mutants for MEK1/2 effects. 32P-Labeling studies confirm several of these effects of kinase pathway modulators on DAT phosphorylation. DAT expression and activities can be regulated by kinase cascades that require phosphoacceptor sites most concentrated in its N terminus. These results have a number of implications for DAT regulation and mandate caution in using DAT radioligand binding to infer changes in dopaminergic neuronal integrity after treatments that alter activities of these kinase pathways.


Received for publication, September 18, 2002 , and in revised form, March 25, 2003.

* This work was supported by NIDA/IRP of the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} These authors contributed equally to this work.

§ To whom correspondence should be addressed: Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, 5500 Nathan Shock Dr., Baltimore, MD 21224. Tel.: 410-550-2843 (ext. 146); Fax: 410-550-2846; E-mail: guhl{at}intra.nida.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. J. Samuvel, L. D. Jayanthi, S. Manohar, K. Kaliyaperumal, R. E. See, and S. Ramamoorthy
Dysregulation of Dopamine Transporter Trafficking and Function after Abstinence from Cocaine Self-Administration in Rats: Evidence for Differential Regulation in Caudate Putamen and Nucleus Accumbens
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Zapata, B. Kivell, Y. Han, J. A. Javitch, E. A. Bolan, D. Kuraguntla, V. Jaligam, M. Oz, L. D. Jayanthi, D. J. Samuvel, et al.
Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors
J. Biol. Chem., December 7, 2007; 282(49): 35842 - 35854.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. A. Bolan, B. Kivell, V. Jaligam, M. Oz, L. D. Jayanthi, Y. Han, N. Sen, E. Urizar, I. Gomes, L. A. Devi, et al.
D2 Receptors Regulate Dopamine Transporter Function via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent and Phosphoinositide 3 Kinase-Independent Mechanism
Mol. Pharmacol., May 1, 2007; 71(5): 1222 - 1232.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Jayanthi, B. Annamalai, D. J. Samuvel, U. Gether, and S. Ramamoorthy
Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization
J. Biol. Chem., August 18, 2006; 281(33): 23326 - 23340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Miranda, C. C. Wu, T. Sorkina, D. R. Korstjens, and A. Sorkin
Enhanced Ubiquitylation and Accelerated Degradation of the Dopamine Transporter Mediated by Protein Kinase C
J. Biol. Chem., October 21, 2005; 280(42): 35617 - 35624.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. D. Jayanthi, D. J. Samuvel, R. D. Blakely, and S. Ramamoorthy
Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation
Mol. Pharmacol., June 1, 2005; 67(6): 2077 - 2087.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Samuvel, L. D. Jayanthi, N. R. Bhat, and S. Ramamoorthy
A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression
J. Neurosci., January 5, 2005; 25(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Vaughan
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Jayanthi, D. J. Samuvel, and S. Ramamoorthy
Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters: EVIDENCE FOR LOCALIZATION IN LIPID RAFTS AND LIPID RAFT-MEDIATED INTERNALIZATION
J. Biol. Chem., April 30, 2004; 279(18): 19315 - 19326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.